(Q38465242)

3 September 2017

title

Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters (English)

1 reference

3 September 2017

5

Old LJ

1 reference

3 September 2017

Busam KJ

1

1 reference

3 September 2017

Iversen K

2

1 reference

3 September 2017

Berwick M

3

1 reference

3 September 2017

Spagnoli GC

4

1 reference

3 September 2017

Jungbluth AA

6

1 reference

3 September 2017

publication date

1 April 2000

1 reference

3 September 2017

1 reference

3 September 2017

volume

13

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

459-465

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3880078

3 September 2017

exact match

0 references

cites work

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Structure, chromosomal localization, and expression of 12 genes of the MAGE family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Expression of MAGE genes in primary and metastatic cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines.

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

21 January 2018

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Immunophenotyping of melanomas for tyrosinase: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

21 January 2018

Cancer Tumor antigens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

Expression of mage genes by non-small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

Expression of MAGE genes in human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

The biologic forms of malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

The classification of malignant melanoma and its histologic reporting

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880078

7 January 2021

10.1038/MODPATHOL.3880078

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1019824068

0 references

1 reference